FOR UK HEALTHCARE PROFESSIONALS ONLY
Please click here for Prescribing Information and further information about Staladex. Adverse event reporting can be found at the bottom of the page.
Cost Savings
Designed to save…
Staladex® is now the least expensive 3-monthly LHRH agonist available in the UK.1
In a study, it was estimated that the leuprorelin implant saved a total of approximately 30 hours of labour time per 1000 patients per year when compared with three common LHRH agonist formulations due to less preparation time.2
A cost assessment study conducted in Europe, found that a leuprorelin solid implant* was associated with potential administration cost savings compared with the most commonly used LHRH agonist preparations.2
Contact us to request a bespoke savings report for your locality.
Footnotes
LHRH, luteinising hormone-releasing hormone
* Leuprorelin–Sandoz® was used for purposes of investigation
References
- UK Drug Tariff (Accessed March 2025)
- Merseburger, A.S., Björk, T., Whitehouse, J. and Meani, D., 2015. Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulations. Journal of comparative effectiveness research, 4(5), pp.447-453.
STA1010606E1_MAR2025
